Närvänen A - Search Results

1

Peptide labelling strategies for imaging agents.

Huhtala T, Weisell J, Rytkönen J, Närvänen A. Huhtala T, et al. Among authors: narvanen a. Methods Mol Biol. 2014;1088:171-83. doi: 10.1007/978-1-62703-673-3_12. Methods Mol Biol. 2014. PMID: 24146404

2

Novel target for peptide-based imaging and treatment of brain tumors.

Hyvönen M, Enbäck J, Huhtala T, Lammi J, Sihto H, Weisell J, Joensuu H, Rosenthal-Aizman K, El-Andaloussi S, Langel U, Närvänen A, Bergers G, Laakkonen P. Hyvönen M, et al. Among authors: narvanen a. Mol Cancer Ther. 2014 Apr;13(4):996-1007. doi: 10.1158/1535-7163.MCT-13-0684. Epub 2014 Feb 3. Mol Cancer Ther. 2014. PMID: 24493698 Free PMC article.

3

SPECT/CT imaging of baculovirus biodistribution in rat.

Räty JK, Liimatainen T, Huhtala T, Kaikkonen MU, Airenne KJ, Hakumäki JM, Närvänen A, Ylä-Herttuala S. Räty JK, et al. Among authors: narvanen a. Gene Ther. 2007 Jun;14(12):930-8. doi: 10.1038/sj.gt.3302934. Epub 2007 Apr 5. Gene Ther. 2007. PMID: 17410181

4

Targeted magnetic resonance imaging of Scavidin-receptor in human umbilical vein endothelial cells in vitro.

Mäntylä T, Hakumäki JM, Huhtala T, Närvänen A, Ylä-Herttuala S. Mäntylä T, et al. Among authors: narvanen a. Magn Reson Med. 2006 Apr;55(4):800-4. doi: 10.1002/mrm.20834. Magn Reson Med. 2006. PMID: 16526021 Free article.

5

In vivo SPECT/CT imaging of human orthotopic ovarian carcinoma xenografts with 111In-labeled monoclonal antibodies.

Huhtala T, Laakkonen P, Sallinen H, Ylä-Herttuala S, Närvänen A. Huhtala T, et al. Among authors: narvanen a. Nucl Med Biol. 2010 Nov;37(8):957-64. doi: 10.1016/j.nucmedbio.2010.03.001. Nucl Med Biol. 2010. PMID: 21055627

6

Biodistribution and antitumor effect of Cetuximab-targeted lentivirus.

Huhtala T, Kaikkonen MU, Lesch HP, Viitala S, Ylä-Herttuala S, Närvänen A. Huhtala T, et al. Among authors: narvanen a. Nucl Med Biol. 2014 Jan;41(1):77-83. doi: 10.1016/j.nucmedbio.2013.10.005. Epub 2013 Oct 18. Nucl Med Biol. 2014. PMID: 24267054

7

Porous silicon-cell penetrating peptide hybrid nanocarrier for intracellular delivery of oligonucleotides.

Rytkönen J, Arukuusk P, Xu W, Kurrikoff K, Langel U, Lehto VP, Närvänen A. Rytkönen J, et al. Among authors: narvanen a. Mol Pharm. 2014 Feb 3;11(2):382-90. doi: 10.1021/mp4002624. Epub 2013 Dec 30. Mol Pharm. 2014. PMID: 24341621

8

(Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery.

Kaikkonen MU, Lesch HP, Pikkarainen J, Räty JK, Vuorio T, Huhtala T, Taavitsainen M, Laitinen T, Tuunanen P, Gröhn O, Närvänen A, Airenne KJ, Ylä-Herttuala S. Kaikkonen MU, et al. Among authors: narvanen a. Gene Ther. 2009 Jul;16(7):894-904. doi: 10.1038/gt.2009.47. Epub 2009 May 14. Gene Ther. 2009. PMID: 19440224

9

Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis.

Huhtala T, Rytkönen J, Jalanko A, Kaasalainen M, Salonen J, Riikonen R, Närvänen A. Huhtala T, et al. Among authors: narvanen a. J Drug Deliv. 2012;2012:626417. doi: 10.1155/2012/626417. Epub 2012 Jun 15. J Drug Deliv. 2012. PMID: 22778966 Free PMC article.

10

Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration.

Näkki S, Rytkönen J, Nissinen T, Florea C, Riikonen J, Ek P, Zhang H, Santos HA, Närvänen A, Xu W, Lehto VP. Näkki S, et al. Among authors: narvanen a. Acta Biomater. 2015 Feb;13:207-15. doi: 10.1016/j.actbio.2014.11.019. Epub 2014 Nov 20. Acta Biomater. 2015. PMID: 25463492

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters